Parallax Volatility Advisers
KYNB

Parallax Volatility Advisers’s Kyntra Bio KYNB Stock Holding History

Parallax Volatility Advisers’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-400
Closed -$8.92K – 2103
2024
Q2 		$8.92K Buy
+400
New +$12.4K ﹤0.01% 1877
2017
Q1 		– Sell
-640
Closed -$342K – 3862
2016
Q4 		$342K Hold
640
– – ﹤0.01% 1658
2016
Q3 		$331K Buy
+640
New +$301K ﹤0.01% 1653

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
GC
GFG Capital Miami, Florida $363M AUM 45.53% 1-Year Est. Return

Parallax Volatility Advisers's KYNB Position: Q2 2019 in Review

Parallax Volatility Advisers sold out of Kyntra Bio (KYNB) in Q2 2019, closing a stake of 22 shares — an estimated $30K sold.

Parallax Volatility Advisers first reported a position in KYNB in Q4 2017 and held it in 4 quarters. The position peaked at $4.12M in Q2 2018. 190 funds tracked by Wall St. Rank hold KYNB as of Q2 2019.

  • Parallax Volatility Advisers reported no remaining Kyntra Bio position as of Q2 2019 after selling out during the quarter.
  • Parallax Volatility Advisers sold 22 Kyntra Bio shares in Q2 2019, an estimated $30K.
  • Parallax Volatility Advisers first reported a position in Kyntra Bio in Q4 2017 and held it in 4 quarters.
  • Parallax Volatility Advisers's Kyntra Bio position peaked at $4.12M in Q2 2018.
  • 190 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2019.

Based on Parallax Volatility Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.